Participation in adjuvant clinical breast cancer trials: Is there a difference in survival compared to guideline adherent adjuvant treatment? A retrospective multicenter cohort study of 5,326 patients.
Achim Wöckel
No relevant relationships to disclose
Reyn Van Ewijk
No relevant relationships to disclose
Isabell Hoffmann
No relevant relationships to disclose
Jochem König
No relevant relationships to disclose
Rolf Kreienberg
No relevant relationships to disclose
Maria Blettner
No relevant relationships to disclose
Lukas Schwentner
No relevant relationships to disclose